RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (68)
Oxidative damage to nucleic acids in human prion disease.
Risk-taking behaviors among motorcyclists in middle east countries: a case of islamic republic of Iran.
CoVaccine HT? Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.
Efficient, fast and robust degradation of chlortetracycline in wastewater catalyzed by recombinant Arthromyces ramosus peroxidase.
Past, present, and future technologies for oral delivery of therapeutic proteins.
See All 68 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Past, present, and future technologies for oral delivery of therapeutic proteins.
Singh R, Singh S, Lillard JW. Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci. 2008 Jul; 97(7):2497-523.
View in:
PubMed
subject areas
Absorption
Administration, Oral
Biocompatible Materials
Drug Carriers
Drug Delivery Systems
Drug Stability
Liposomes
Nanoparticles
Particle Size
Polymers
Proteins
Technology, Pharmaceutical
authors with profiles
Shailesh Singh
James Lillard
Rajesh Singh